Literature DB >> 18453850

Designing and interpreting HIV noninferiority trials in naive and experienced patients.

Andrew Hill1, Caroline Sabin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18453850     DOI： 10.1097/QAD.0b013e3282f5556d

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  8 in total

1.  Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.

Authors:  Derrick W Crook; A Sarah Walker; Yin Kean; Karl Weiss; Oliver A Cornely; Mark A Miller; Roberto Esposito; Thomas J Louie; Nicole E Stoesser; Bernadette C Young; Brian J Angus; Sherwood L Gorbach; Timothy E A Peto
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

Review 2.  Deficient reporting and interpretation of non-inferiority randomized clinical trials in HIV patients: a systematic review.

Authors:  Adrian V Hernandez; Vinay Pasupuleti; Abhishek Deshpande; Priyaleela Thota; Jaime A Collins; Jose E Vidal
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

Review 3.  Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis.

Authors:  Sandra Mathis; Bettina Khanlari; Federico Pulido; Mauro Schechter; Eugenia Negredo; Mark Nelson; Pietro Vernazza; Pedro Cahn; Jean-Luc Meynard; Jose Arribas; Heiner C Bucher
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

4.  Statistical methods in recent HIV noninferiority trials: reanalysis of 11 trials.

Authors:  Philippe Flandre
Journal:  PLoS One       Date:  2011-09-07       Impact factor: 3.240

Review 5.  Etravirine as a Switching Option for Patients with HIV RNA Suppression: A Review of Recent Trials.

Authors:  Mark Nelson; Andrew Hill; Yvon van Delft; Christiane Moecklinghoff
Journal:  AIDS Res Treat       Date:  2014-02-25

6.  Editorial commentary: Comparative efficacy of lamivudine and emtricitabine: comparing the results of randomized trials and cohorts.

Authors:  Nathan Ford; Andrew Hill; Marco Vitoria; Edward J Mills
Journal:  Clin Infect Dis       Date:  2014-10-01       Impact factor: 9.079

7.  Choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?

Authors:  Marco Vitoria; Andrew M Hill; Nathan P Ford; Meg Doherty; Saye H Khoo; Anton L Pozniak
Journal:  J Int AIDS Soc       Date:  2016-02-02       Impact factor: 5.396

8.  Superiority and non-inferiority: two sides of the same coin?

Authors:  David T Dunn; Andrew J Copas; Peter Brocklehurst
Journal:  Trials       Date:  2018-09-17       Impact factor: 2.279
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.